Genocury
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 6
About Genocury
Based in Shenzhen, China, and established in 2021, Genocury is a biotechnology company that focuses on the R&D of f gene and cell therapies for cancers. The core R&D team has experience in the fields of cell therapy and gene therapy. The company mainly provides gene and cell therapies for tumours. Its products include vivo CAR-T (Chimeric Antigen Receptor T-Cell Therapy) for lymphoma, general NK cellular fluid for blood tumours, and CAR-NK (Chimeric Antigen Receptor NK Cell Therapy) for prostate, ovarian, pancreatic, and lung cancers, based on a gene editing technology platform, and an iPS hematopoietic directional differentiation platform. The in vivo CAR-T therapeutic drugs have completed preclinical development. The company generates revenue by providing gene and cell therapies for tumours.
Who invested in Genocury
6 investors across 4 rounds
See all investors in Genocury
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genocury
Who invested in Genocury?
Genocury has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genocury raised?
Genocury has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Genocury last raise money?
Genocury's most recent round on record is a Series A, in Sep 2025.
What does Genocury do?
Based in Shenzhen, China, and established in 2021, Genocury is a biotechnology company that focuses on the R&D of f gene and cell therapies for cancers.
Where is Genocury headquartered?
Genocury is headquartered in Shenzhen, China.
Which VCs invest in companies like Genocury?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genocury's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Genocury? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.